Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
373
datasets available to search
ShareScore release 0.9.0
Dataset results
373 results for “chronic myeloid leukemia”
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
ClinicalTrials.gov study NCT05143840. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant
ClinicalTrials.gov study NCT00413270. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Investigating Intracellular and Plasma Imatinib Levels in Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00947830. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Leukemic Stem Cell Detection for Chronic Myeloid Leukemia Patients With Major Molecular Response
ClinicalTrials.gov study NCT04104035. IPD Sharing: NO. Countries: 1. Publications: 0.
Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase
ClinicalTrials.gov study NCT01802450. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT05304377. IPD Sharing: NO. Countries: 14. Publications: 0.
Discontinuation of TyrosIne Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) and Impact on the Immune System
ClinicalTrials.gov study NCT05753384. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bosutinib in Elderly Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT02810990. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients with Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT04147533. IPD Sharing: NO. Countries: 1. Publications: 0.
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitor in Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT05259228. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma
ClinicalTrials.gov study NCT00003885. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase
ClinicalTrials.gov study NCT00084916. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of CBX-250 in Participants With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
ClinicalTrials.gov study NCT06994676. IPD Sharing: YES. Countries: 1. Publications: 0.
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic M
ClinicalTrials.gov study NCT04375631. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Treatment Free Remission in Patients With Chronic Myeloid Leukemia in Chronic Phase
ClinicalTrials.gov study NCT05926128. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
ClinicalTrials.gov study NCT00428909. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Quality of Life and Care Organization of Patients With Chronic Myeloid Leukemia in the Lombardy Hematology Network
ClinicalTrials.gov study NCT07165535. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Digital Health Coaching Program on Self-efficacy and Patient Reported Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT04774744. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndr
ClinicalTrials.gov study NCT00038805. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treating Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) With Dasatinib
ClinicalTrials.gov study NCT02348957. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.